fNIRS for Disorders of Consciousness
Functional Near-infrared Spectroscopy in Disorders of Consciousness: Protocol Testing and Pilot in Neuro-ICU Setting
1 other identifier
observational
55
1 country
1
Brief Summary
The goal of this observational study is to learn whether functional near-infrared spectroscopy (fNIRS) can measure brain activity in healthy adults and in people with disorders of consciousness (DoC) in the neuro-intensive care unit (Neuro-ICU). DoC include conditions such as coma and minimally conscious state that occur after severe brain injury. These conditions make it difficult to assess a person's level of awareness because many clinical tests rely on observable behaviors such as speaking or moving, which are commonly impaired after brain injury. The main questions the study aims to answer are:
- Can fNIRS detect changes in brain activity in healthy adults when they receive sensory stimulation or perform mental tasks?
- Can the same fNIRS protocol be used in patients with disorders of consciousness in the Neuro-ICU to measure brain responses and determine whether the method is feasible in this clinical setting? The investigators will first study healthy adult volunteers to establish baseline brain responses and determine which tasks produce the most reliable signals. The protocol will then be applied to patients with disorders of consciousness admitted to the Neuro-ICU. Participants will take part in a single research session lasting about 30 to 45 minutes while wearing the lightweight fNIRS headband that measures brain oxygen levels using near-infrared light. During the session, participants will:
- Wear a non-invasive fNIRS headband placed on the forehead
- Receive gentle sensory stimulation (for example, compression devices on the legs or hands)
- Listen to sounds or spoken sentences
- Perform guided mental tasks such as imagining walking through their home or imagining moving a limb The study does not test a treatment and will not change medical care. The goal is to determine whether fNIRS can safely and reliably measure brain activity at the bedside and provide preliminary information that may help guide future research on improving the assessment of consciousness after brain injury.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 16, 2026
CompletedFirst Posted
Study publicly available on registry
March 20, 2026
CompletedStudy Start
First participant enrolled
May 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
June 8, 2026
June 1, 2026
7 months
March 16, 2026
June 4, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Task-evoked cortical hemodynamic response measured with functional near-infrared spectroscopy (fNIRS)
Cortical hemodynamic responses measured using fNIRS, quantified as changes in oxygenated hemoglobin (HbO) and deoxygenated hemoglobin (HbR) during somatosensory and cognitive task paradigms relative to rest periods.
During a single fNIRS recording session (approximately 20-48 minutes, depending on participant group)
Study Arms (2)
Healthy Control Participants
Healthy adult participants undergo functional near-infrared spectroscopy (fNIRS) monitoring during a series of sensory and cognitive paradigms to characterize baseline hemodynamic responses and establish reference patterns in individuals with intact cognition.
Patients with Disorders of Consciousness
Patients with disorders of consciousness (DoC) admitted to the neuro-intensive care unit undergo functional near-infrared spectroscopy (fNIRS) monitoring using the refined paradigm to evaluate feasibility and obtain preliminary observations of cortical hemodynamic responses in this population.
Interventions
Participants undergo functional near-infrared spectroscopy (fNIRS) monitoring while exposed to a structured series of passive sensory stimuli and guided mental tasks designed to engage different levels of cognitive processing. Paradigms include somatosensory stimulation, auditory processing, semantic language processing, spatial navigation imagery, and motor imagery. Hemodynamic responses are measured as changes in oxygenated and deoxygenated hemoglobin.
Eligibility Criteria
The study population includes two groups: healthy adult volunteers and patients with DoC admitted to the neuro-intensive care unit. Healthy participants will be recruited from the local community and university population to establish baseline fNIRS responses during sensory and cognitive paradigms. Patients with DoC will be recruited from the Neuro-ICU at the participating medical center and include individuals with impaired consciousness following acute brain injury who meet the study eligibility criteria.
You may qualify if:
- Healthy Control Participants:
- Age 18 years or older
- Proficient in English language
- Intact cognition
- Montreal Cognitive Assessment (MoCA) score \> 26
- DoC Patients:
- Age 18 years or older
- Proficient in English language
- Surrogate decision maker available
- Admission to the intensive care unit within 28 days
- Documented Glasgow Coma Scale (GCS) score
- Auditory Function subscale score ≥1 on the Coma Recovery Scale-Revised (CRS-R)
You may not qualify if:
- Healthy Control Participants:
- Known baseline hearing impairment without available hearing aids
- Neurological or psychiatric history
- DoC Patients:
- Known baseline hearing impairment without available hearing aids
- Inability to obtain informed consent
- Extensive bilateral frontal injury on available imaging (CT/MRI)
- Patients who have undergone craniectomy surgery
- IV sedation in the past 24 hours
- Absent auditory startle response (\<1 from Auditory Function subscale score of CRS-R)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UCLA School of Nursing; Ronald Reagan Medical Center
Los Angeles, California, 90095, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 16, 2026
First Posted
March 20, 2026
Study Start
May 1, 2026
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
June 8, 2026
Record last verified: 2026-06